Back
Markel Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
34
MKL
Markel Group
Last Price:
$1,838.15
Seasonality Move:
3.19%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$51.82
Seasonality Move:
-12.73%
Sell
34
Markel Group (MKL)
is a Sell
Is Markel Group a Buy, Sell or Hold?
-
The current Markel Group [MKL] share price is $1,838.16. The Score for MKL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MKL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.79. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MKL Stock Price Chart
What is Markel Group's stock price today?
-
The Markel Group share price today is $1,838.16The current trend is moderately bearish and MKL is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
MKL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 23.65 | Buy |
Relative Strength Index (14 RSI): | 48.1 | Sell |
Chaikin Money Flow: | -56084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1787.66 - 1933.4) | Sell |
Bollinger Bands (100): | (1595.27 - 1828.19) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.23 | Buy |
Relative Strength Index (14 RSI): | 65.31 | Buy |
Chaikin Money Flow: | -120893 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.17 - 57.71) | Buy |
Bollinger Bands (100): | (24.28 - 43.14) | Buy |
MKL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1879.08 | Sell |
20-day SMA: | 1878.01 | Sell |
50-day SMA: | 1791.6 | Buy |
200-day SMA: | 1645.79 | Buy |
8-day EMA: | 1872.65 | Sell |
20-day EMA: | 1864.65 | Sell |
50-day EMA: | 1806.4 | Buy |
200-day EMA: | 1661.68 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.2 | Buy |
20-day SMA: | 51.13 | Buy |
50-day SMA: | 36.86 | Buy |
200-day SMA: | 28.92 | Buy |
8-day EMA: | 50.79 | Buy |
20-day EMA: | 47.87 | Buy |
50-day EMA: | 40.71 | Buy |
200-day EMA: | 31.81 | Buy |
Markel Group Earnings Growth & MKL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.22 per share, an increase next quarter of $2.46 per share, an increase this year of $8.19 per share, and an increase next year of $16.99 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Markel Group Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |